Product: Deferoxamine Mesylate for injection, USP, Single-use Vial, 500 mg/vial, 10 mL vial. Intravenous, Intramuscular, Subcutaneous Use, Rx Only, Hospira, Inc., Lake Forest IL USA, NDC 0406-2336-10.
Reason for recall: CGMP Deviations: Firm failed to control impurity for color change at the API stage.
Recall initiated: 20170712
Status: Terminated
Classification: Class III
Recall type: Voluntary: Firm initiated